Aydin, E., & Demir, H. D. (2012). Intravitreal bevacizumab for the treatment of retinal neovascularization secondary to ocular toxoplasmosis. Turkiye Klinikleri Journal of Medical Sciences, 32(2), 529-532.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Aydin, Erdinc, y Helin Deniz Demir. "Intravitreal Bevacizumab for the Treatment of Retinal Neovascularization Secondary to Ocular Toxoplasmosis."
Turkiye Klinikleri Journal of Medical Sciences 32, no. 2 (2012): 529-532.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Aydin, Erdinc, y Helin Deniz Demir. "Intravitreal Bevacizumab for the Treatment of Retinal Neovascularization Secondary to Ocular Toxoplasmosis."
Turkiye Klinikleri Journal of Medical Sciences, vol. 32, no. 2, 2012, pp. 529-532.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.